FDA Panel Backs Eisai/MGI's Aquavan - With Proviso

FDA's Anesthetic and Life Support Drugs Advisory Committee voted 6-3 with one abstention May 7 to recommend approval of Eisai/MGI Pharma's Aquavan (fospropofol) for sedation in adult patients undergoing diagnostic or therapeutic procedures